PPARa AGONIST COMPOSITIONS AND METHODS OF USE
US-2020297651-A1 · Sep 24, 2020 · US
Eyedrops for ameliorating or preventing retinal circulation disorder and retinal neurovascular coupling disorder
US2024415796A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2024415796-A1 |
| Application number | US-202118253096-A |
| Country | US |
| Kind code | A1 |
| Filing date | Nov 19, 2021 |
| Priority date | Nov 19, 2020 |
| Publication date | Dec 19, 2024 |
| Grant date | — |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Eyedrops for ameliorating retinal circulation disorder and retinal neurovascular coupling disorder, the eyedrops containing fibrate-containing nanoparticles.
First claim
Opening claim text (preview).
1 . An eyedrop for ameliorating or preventing retinal circulation disorder and a retinal neurovascular coupling disorder, the eyedrop comprising nanoparticles including a fibrate, wherein the nanoparticles are a wet-ground product of a fibrate, and the nanoparticles have a particle diameter in the range of 10 to 300 nm. 2 . (canceled) 3 . The eyedrop according to claim 1 , further comprising a thickener. 4 . The eyedrop according to claim 3 , wherein the thickener is a cellulose-based thickener. 5 . The eyedrop according to claim 4 , wherein the cellulose-based thickener is methylcellulose. 6 . The eyedrop according to claim 1 , further comprising cyclodextrins. 7 . The eyedrop according to claim 6 , wherein the cyclodextrins are 2-hydroxypropyl-β-cyclodextrin. 8 . The method for ameliorating or preventing retinal circulation disorder or retinal neurovascular coupling disorder, the method comprising administering the eyedrop comprising nanoparticles including a fibrate to a subject, wherein the nanoparticles are a wet-ground product of a fibrate, and the nanoparticles have a particle diameter in the range of 10 to 300 nm. 9 . The method according to claim 8 , wherein the eyedrop further comprises a thickener. 10 . The method according to claim 9 , wherein the thickener is a cellulose-based thickener. 11 . The method according to claim 10 , wherein the cellulose-based thickener is methylcellulose. 12 . The method according to claim 8 , wherein the eyedrop further comprises cyclodextrins. 13 . The method according to claim 12 , wherein the cyclodextrins are 2-hydroxypropyl-β-cyclodextrin.
Assignees
Inventors
Classifications
Cyclodextrins; Derivatives thereof · CPC title
Cellulose; Derivatives thereof · CPC title
Nanocapsules; {Nanoparticles; (nanotubes A61K9/0092; polymeric micelles A61K9/1075; polymersomes A61K9/1273; pure drug nanoparticles A61K9/14; drug nanoparticles with adsorbed surface modifiers A61K9/141; conjugates, e.g. between drug and non-active nanoparticles, A61K47/50; preparations for in vivo diagnosis A61K49/00; with radioactive substances A61K51/00)} · CPC title
Eye, e.g. artificial tears · CPC title
- A61P27/02Primary
Ophthalmic agents · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US2024415796A1 cover?
- Eyedrops for ameliorating retinal circulation disorder and retinal neurovascular coupling disorder, the eyedrops containing fibrate-containing nanoparticles.
- Who is the assignee on this patent?
- Univ Nihon, Univ Kinki
- What technology area does this patent fall under?
- Primary CPC classification A61P27/02. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Thu Dec 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).